Adoptive immunotherapy of experimental tumors using cytotoxic lymphocytes to carry and deliver toxins.
Adoptive transfer of specifically sensitized lymphoid cells constitutes a potential tool for specific cancer immunotherapy, however, the requirement of syngeneic or autologous specifically reactive cells has limited its use in the treatment of human cancer. In several mouse tumor models, large amoun...
Main Authors: | Zanovello, P, Rosato, A, Bronte, V, Cerundolo, V, Collavo, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1991
|
Similar Items
-
Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity.
by: Zanovello, P, et al.
Published: (1989) -
Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases.
by: Zanovello, P, et al.
Published: (1992) -
Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
by: Ronchese, F, et al.
Published: (1985) -
Generation and enrichment of antigen-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
by: Oelke, M, et al.
Published: (2000) -
Reduction in precursors of cytotoxic T lymphocytes and of cells with natural killer-like activity in spleens of cyclophosphamide-treated mice.
by: Collavo, D, et al.
Published: (1984)